Floatz logo

159 assets in Cervical Cancer

Therapeutic assets addressing Cervical Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Spedox-6
Cervical Cancer
University of California, IrvineP1/2CC (41)
Tarlatamab
Cervical Cancer
University of ArizonaP1/2CC (41)
T-Dxd
Cervical Cancer
AstraZenecaP1/2CC (41)
Ter-2013
Cervical Cancer
Terremoto Biosciences Inc.P1/2CC (41)
xnw5004
Cervical Cancer
Evopoint Biosciences Inc.P1/2CC (41)
Cnsi-Fe
Cervical Cancer
Sichuan Enray Pharmaceutical Sciences CompanyP1CC (40)
NC 410
Cervical Cancer
NextCure, Inc.P1/2CC (40)
rp903
Cervical Cancer
Risen (Suzhou) Pharma Tech Co., Ltd.P1CC (40)
Zimberelimab
Cervical Cancer
Arcus Biosciences, Inc.P1CC (40)
PRT1419
Cervical Cancer
Prelude TherapeuticsP1C (39)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Cervical Cancer
Nurix Therapeutics, Inc.P1C (37)
²¹²pb-dotam-grpr1
Cervical Cancer
Orano Med Theranostics, SASP1C (37)
ab598
Cervical Cancer
Arcus Biosciences, Inc.P1C (37)
Adrx-0706
Cervical Cancer
Adcentrx TherapeuticsP1C (37)
ai-061
Cervical Cancer
OncoC4, Inc.P1C (37)
Alpaloritovorelli Antibodies
Cervical Cancer
Anhui Provincial HospitalP1C (37)
an0025
Cervical Cancer
Adlai Nortye Biopharma Co., Ltd.P1C (37)
Astx 660
Cervical Cancer
Institute of Cancer Research, United KingdomP1C (37)
Bl-M07D1
Cervical Cancer
SystImmune Inc.P1C (37)
Crte7A2-01 Tcr-T Cell
Cervical Cancer
Corregene Biotechnology Co., LtdP1C (37)
Crte7A2-01 Tcr-T Cell Therapy
Cervical Cancer
Corregene Biotechnology Co., LtdP1C (37)
dr-0202
Cervical Cancer
Dren BioP1C (37)
Drug Product De-Til-0255
Cervical Cancer
Nurix Therapeutics, Inc.P1C (37)
Emunkitug
Cervical Cancer
HiFiBiO TherapeuticsP1C (37)
H-Gamma1 Heavy Chain Humanized (1-449) [Vh (Homo Sapiens Ighv3-23*01 (81.6%) -(Ighd) -Ighj3*02 (91.7%) M123>T (114), Cdr-Imgt [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo Sapiens Ighg1*03V (100%) G1M3>G1M17, Ng1M1 Ch1 K120, Ch3 E12, M14 (Ch1 R120>K (216) (120-217), Hinge 1-15 (218-232), Ch2 (233-342), Ch3 E12 (358), M14 (360) (343-447), Chs (448-449)) (120-449)], (222-218')-Disulfide With L-Kappa Light Chain Humanized (1'-218') [Vkappa (Homo Sapiens Igkv1-33*01 (87.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.13] (27'-32'.50'-52'.89'-101')) (1'-111')-Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (C-Kappaa45.1 (157'), V101 (195')) (112'-218')]; Dimer (228-228'':231-231'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa
Cervical Cancer
Genentech, Inc.P1C (37)
hh160
Cervical Cancer
Huahui HealthP1C (37)
Hryz-T101
Cervical Cancer
HRYZ Biotech Co.P1C (37)
Hryz-T101 Tcr-T Cell
Cervical Cancer
HRYZ Biotech Co.P1C (37)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Cervical Cancer
SystImmune Inc.P1C (37)
Itil-168
Cervical Cancer
Instil BioP1C (37)
Kk-Lc-1 Tcr-T Cells
Cervical Cancer
Christian HinrichsP1C (37)
Loperamide
Cervical Cancer
M.D. Anderson Cancer CenterP1C (37)
ly4052031
Cervical Cancer
Eli Lilly and CompanyP1C (37)
ly4101174
Cervical Cancer
Eli Lilly and CompanyP1C (37)
MGC026
Cervical Cancer
MacroGenicsP1C (37)
mt-8421
Cervical Cancer
Molecular Templates, Inc.P1C (37)
ngm438
Cervical Cancer
NGM Biopharmaceuticals, IncP1C (37)
ngm831
Cervical Cancer
NGM Biopharmaceuticals, IncP1C (37)
Nrm-823
Cervical Cancer
Normunity AccelCo, Inc.P1C (37)
Oxaliplatin
Cervical Cancer
Arcus Biosciences, Inc.P1C (37)
Phn-010
Cervical Cancer
Pheon TherapeuticsP1C (37)
rad301
Cervical Cancer
Radiopharm Theranostics, LtdP1C (37)
Rgt-490
Cervical Cancer
Regor Pharmaceuticals Inc.P1C (37)
Rndo-564
Cervical Cancer
Rondo TherapeuticsP1C (37)
scg142 tcr-t cells
Cervical Cancer
The Affiliated Hospital of Qingdao UniversityP1C (37)
Stro-004
Cervical Cancer
Sutro Biopharma, Inc.P1C (37)
Tislelizumab
Cervical Cancer
HiFiBiO TherapeuticsP1C (37)
Tsc-200-A0201
Cervical Cancer
TScan Therapeutics, Inc.P1C (37)
Tsc-201-B0702
Cervical Cancer
TScan Therapeutics, Inc.P1C (37)
Tsc-202-A0201
Cervical Cancer
TScan Therapeutics, Inc.P1C (37)
Showing 101 to 150 of 159 assets
PreviousPage 3 of 4Next